Bloom MD review

Two pricing structures live on the same site and they point in opposite directions. Tirzepatide is genuinely dose-scaled, with five rungs and a milligram figure against each, which is the structure a low-dose buyer wants. Semaglutide is sold explicitly at one price for any dose, which is the structure that costs a low-dose buyer the most. Between them sits a named microdose product priced a whisker below the tirzepatide ladder's lowest rung while publishing no dose at all — so you pay nearly the same money for a quantity you cannot see. The intake is reviewed after purchase rather than before it.

Vs median

$76/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Billed separately

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Bloom MD does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is billed separately.

Bloom MD is a telehealth platform for weight loss, longevity and wellness running on Shopify, selling compounded tirzepatide on a published dose ladder, compounded semaglutide at one flat price across all doses, a separately named microdose tirzepatide product, liraglutide, oral GLP-1 drops and an oral-pill program membership. Its tirzepatide pricing is genuinely dose-scaled, which is rare, and its semaglutide pricing is explicitly not. The site's own FAQ states that a consultation is not required and that the intake is reviewed after purchase rather than before it, and the terms of service name a different operating entity from the trading name.

The named microdose saves four dollars. It is $245/mo against $249/mo for the lowest rung of the standard tirzepatide ladder — and unlike that rung, it publishes no milligram figure at all, so you are paying almost the same money for a dose you cannot see

• Compounded semaglutide is sold explicitly as one price for any dose, so a semaglutide microdoser pays the maximum-dose rate for a fraction of the drug
• The FAQ states a consultation is not required and that intake is reviewed AFTER purchase, which inverts the order a reader would expect from a prescription service
• The terms of service are third-party boilerplate naming an operating entity that does not match the trading name anywhere user-facing
• No compounding pharmacy is named and no 503A/503B designation is given
• Product detail is thin on the rendered pages — most of the catalog is only legible through the storefront's product API
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Bloom MD is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing tirzepatide
• Microdosing semaglutide
• What a flat price costs at a low dose
• Microdose & reconstitution calculator